Intraperitoneal administration of the minor tobacco alkaloid and nicotinic receptor agonist anabaseine was shown to reduce tissue damage, myeloperoxidase activity, and colonic TNFα expression in a TNBS mouse model of colitis [22]. This evidence concerns the gene MPO and colitis.